Last week, the Texas Medical Board signed off on what's said to be the first state-level policy imposing oversight on experimental treatments using adult stem cells. The scientific community has mixed views on whether this is a good way to raise standards. Some experts say the rule will allow unscrupulous doctors to avoid U.S. Food and Drug Administration reviews. But others say it's a good-faith effort to bring oversight to controversial treatments that clinics around the world offer for diseases including arthritis and multiple sclerosis.
Texas Medical Board Approves Rules for Controversial Treatment
Magazine Content Preview
- Posted in
- Biomedicine
Related on Insider
)
)
)
Recent Articles
- U.S. Senate Confirms Ernest Moniz as Secretary of Energy
- In 'Insurrection,' Scientists, Editors Call for Abandoning Journal Impact Factors
- NSF Says No to Congressman's Request for Reviewer Comments
- Malfunction Could Mark the End of NASA's Kepler Mission
- 'MERS' Makes Its Debut in a Scientific Journal
- Institut Pasteur Fights Claims of Financial Mismanagement
Categories
- Anthropology (32)
- Asia (221)
- Astronomy (33)
- Biology (1)
- Biomedicine (706)
- Botany (3)
- Budget (442)
- Defense (96)
- Earth Science (18)
- Ecology (171)
- Education (258)
- Energy (196)
- Environment/Climate (428)
- Europe (432)
- Evolution (6)
- Genetics (8)
- Medicine (17)
- Physical Science (84)
- Physics (92)
- Science Community (136)
- Space (139)
- Swine Flu (127)
- Technology (73)
- Top Story (112)
- White House (148)
Questions or feedback on this page?
Let us know.
News | Science Journals | Careers | Blogs and Communities | Multimedia | Collections | Help | Site Map | RSS
Subscribe | Feedback | Privacy Policy | About Us | Advertise With Us | Contact Us
© 2010 American Association for the Advancement of Science. All Rights Reserved.
AAAS is a partner of HINARI, AGORA, OARE, PatientInform, CrossRef, and COUNTER.